US 10723777
Peptide having anti-obesity and anti-diabetes efficacy and use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 10723777 (Peptide having anti-obesity and anti-diabetes efficacy and use thereof) held by CAREGEN CO., LTD. expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P3/04, A61P3/10